Overview
Long-acting, complex drug delivery products, particularly those based on microparticles, nanoparticles and implants, are among the most pervasive parenteral products in the pharmaceutical industry. Long-acting injectables that use bioabsorbable polymers for systemic and local drug delivery have improved the lives of millions of patients globally, based on successful outcomes for the treatment of schizophrenia, diabetes, substance abuse, cancer, as well as ocular, rare and hormonal diseases. These products have many advantages including simplification of the drug regimen by decreasing dosing frequency, helping to improve efficacy and treatment adherence.
In this one-day workshop, Evonik’s drug delivery experts will share their experiences and insights on the discovery and development of long-acting injectables, presenting the most advanced polymer-based excipients, products and platforms on the market. They will highlight key properties of bioabsorbable poly(lactide-co-glycolide) polymers and explain their relevance to drug delivery formulations. In addition, our speakers will discuss GMP manufacturing considerations for both parenteral excipients and drug products. Key areas of focus will be product-by-process manufacturing, ocular implants, microparticles and nanoparticles.
What our attendees will learn:- Brief history of long acting polymeric injectable drug products on the market, including microparticles and implants
- Overview of key LG polymer properties and highly specialized polymer grades relevant to drug delivery formulations
- Recent application trends, including immuno-oncology and ocular drug delivery and future trends
- Polymeric and lipid nanoparticles
- Custom polymer and lipid synthesis, parenteral drug services for formulations
